FIORE, MICHELE
 Distribuzione geografica
Continente #
AS - Asia 894
EU - Europa 442
NA - Nord America 384
OC - Oceania 8
AF - Africa 7
SA - Sud America 4
Totale 1.739
Nazione #
SG - Singapore 697
US - Stati Uniti d'America 371
IT - Italia 188
CN - Cina 93
GB - Regno Unito 77
HK - Hong Kong 58
EE - Estonia 43
DE - Germania 39
NL - Olanda 31
IN - India 23
FI - Finlandia 20
CA - Canada 13
CZ - Repubblica Ceca 11
UA - Ucraina 9
AU - Australia 8
ID - Indonesia 8
RO - Romania 8
ZA - Sudafrica 6
FR - Francia 5
SE - Svezia 4
AT - Austria 3
BR - Brasile 3
JP - Giappone 3
TR - Turchia 3
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
BD - Bangladesh 1
BE - Belgio 1
CL - Cile 1
IQ - Iraq 1
KR - Corea 1
KZ - Kazakistan 1
OM - Oman 1
PK - Pakistan 1
RS - Serbia 1
SA - Arabia Saudita 1
SL - Sierra Leone 1
Totale 1.739
Città #
Singapore 193
Ashburn 110
Rome 93
Boardman 82
London 72
Shanghai 66
Hong Kong 53
Amsterdam 24
Helsinki 20
Los Angeles 18
Sona 14
Washington 14
Council Bluffs 13
Milan 13
San Francisco 12
Pune 11
Toronto 10
Brno 9
Munich 9
Seattle 8
West Jordan 8
Nuremberg 7
Redmond 6
Naples 5
Rocca di Papa 5
Cascina 4
Santa Clara 4
Umeå 4
Vicenza 4
Aprilia 3
Buffalo 3
Catania 3
Central 3
Handan 3
Hanover 3
Melbourne 3
Sydney 3
São Paulo 3
Vaddangi 3
Bangalore 2
Banqiao 2
Bratislava 2
Bucharest 2
Canberra 2
Frankfurt am Main 2
Guangzhou 2
Hangzhou 2
Harbin 2
Jakarta 2
Liberty Lake 2
Markham 2
Monte San Giusto 2
Olomouc 2
Palermo 2
Pescara 2
Sant'Anastasia 2
Southall 2
Xi'an 2
Agrate Brianza 1
Almere Stad 1
Andover 1
Beijing 1
Belgrade 1
Brussels 1
Cameri 1
Centurion 1
Chennai 1
Chicago 1
Cleveland 1
Clifton 1
Delhi 1
Dezhou 1
Dhaka 1
Florence 1
Freetown 1
Genoa 1
Haikou 1
Islamabad 1
Jung-gu 1
Karlsruhe 1
Kowloon City 1
Leesburg 1
Marino 1
Miami 1
Muscat 1
Naaldwijk 1
Nanyang 1
Newark 1
Pingdingshan 1
Qingdao 1
Redwood City 1
Riyadh 1
Surabaya 1
Tallinn 1
Temecula 1
Tokyo 1
Vienna 1
Yuncheng 1
Zhengzhou 1
Totale 1.000
Nome #
18F-choline PET/CT driven salvage radiotherapy in prostate cancer patients: up-date analysis with 5-year median follow-up 63
Deep pathomics: A new image-based tool for predicting response to treatment in stage III non-small cell lung cancer 54
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 52
The role of multiparametric magnetic resonance imaging in the diagnosis of local recurrence after radical prostatectomy and before salvage radiotherapy 45
Radiation-induced pneumonitis in the era of the covid-19 pandemic: artificial intelligence for differential diagnosis 38
42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis 33
A bio-imaging signature as a predictor of clinical outcomes in locally advanced pancreatic cancer 32
Early GLS changes detection after chemoradiation in locally advanced non-small cell lung cancer (NSCLC) 31
CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis 30
A clinical score, including biohumoral parameters, is a useful pretest index to discriminate pulmonary infections from radiation damage in chemoradiation-treated lung cancer patients 30
Exploring Deep Pathomics in Lung Cancer 29
NEW TECHNOLOGIES IN RADIOTHERAPY FOR PROSTATE CANCER: FEASIBILITY, DOSIMETRIC ASPECTS AND CLINICAL RESULTS IN PATIENTS WITH AT LEAST 5-YEAR FOLLOW-UP 28
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 27
A Multimodal Ensemble Driven by Multiobjective Optimisation to Predict Overall Survival in Non-Small-Cell Lung Cancer 27
Long term results of a prospective phase 2 study on volume de-escalation in neoadjuvant chemoradiotherapy of rectal cancer 25
The psychological impact of the covid-19 pandemic on radiotherapy cancer patients 23
The impact of intensified staging and combined therapies in locally advanced pancreatic cancer: a secondary analysis of prospective studies 23
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 23
Protective Role of Natural Compounds under Radiation-Induced Injury 23
Concurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: preliminary assessment of toxicity 23
Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer 23
Implementation of a voluntary deep inspiration breath hold technique (vDIBH) using BrainLab ExacTrac infrared optical tracking system. 23
Local Control and Toxicity of Adaptive Radiotherapy Using Weekly CT Imaging: Results from the LARTIA Trial in Stage III NSCLC 23
QUALITY ASSURANCE FOR CLINICAL PRACTICE IN CERVICAL CANCER BRACHYTHERAPY WITH IR-192 SOURCE: IN VIVO DOSIMETRY WITH QED DIODES 22
LPS AND RADIATION-INDUCED GUT PERMEABILITY DAMAGE: FOCUS ON THE POTENTIAL BENEFICIAL EFFECT OF GRAPE SEED EXTRACT 22
Chemoradiation for stage III non-small cell lung cancer 22
Estimating the value of surgical clips for target volume delineation in external beam partial breast radiotherapy 22
A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients 22
Empowering Hepatocellular Carcinoma Ablative Therapy: A Renaissance of Collaboration 21
Breast Volume Is a Predictor of Higher Heart Dose in Whole-Breast Supine Free-Breathing Volumetric-Modulated Arc Therapy Planning 21
Combination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy. 21
Neutrophil to lymphocyte ratio (NLR) and derived neutrophil to lymphocyte ratio (D-NLR) predict non-responders and postoperative complications in patients undergoing radical surgery after neo-adjuvant radio-chemotherapy for rectal adenocarcinoma 21
Beams arrangement in non small-cell lung cancer (NSCLC) according to PTV and dosimetric parameters predictive of pneumonitis 21
Advances in pre-treatment evaluation of pancreatic ductal adenocarcinoma: a narrative review 20
Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer 20
Exploratory Radiomics for Predicting Adaptive Radiotherapy in Non-Small Cell Lung Cancer 20
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME). 20
Delayed surgery after radio-chemotherapy for rectal adenocarcinoma is protective for anastomotic dehiscence: a single-center observational retrospective cohort study 20
Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy 20
Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection 20
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 20
A new three-dimensional conformal radiotherapy (3DCRT) technique for large breast and/or high body mass index patients: evaluation of a novel fields assessment aimed to reduce extra–target-tissue irradiation 19
Clinical results of stereotactic ablative radiotherapy in the treatment of liver metastases 19
RADIOCHEMOTHERAPY FOR LOCALLY-ADVANCED NSCLC: WHICH IS THE BEST ASSOCIATION? FROM CHEMOTHERAPY TO BIOLOGICAL TARGET IN 5 PHASES II TRIALS 19
Factors predicting pathological response to neoadjuvant chemoradiotherapy in rectal cancer: The experience of a single institution with 269 patients (STONE-01) 19
The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: Highlights from the 7th Meeting of AIRO - Young Members Working Group (AIRO Giovani) 18
Clinical practice guidelines for diagnosis, treatment and follow-up of exocrine pancreatic ductal adenocarcinoma: Evidence evaluation and recommendations by the italian association of medical oncology (AIOM) 18
Histologic transformation to small-cell lung cancer following gefitinib and radiotherapy in a patient with pulmonary adenocarcinoma. 18
COVID-19 and radiation induced pneumonitis: Overlapping clinical features of different diseases 17
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 17
Different biliary microbial flora influence type of complications after pancreaticoduodenectomy: a single center retrospective analysis 17
Preliminary results of a phase II study of induction Folfirinox followed by chemoradiation in LAPC 17
MULTIMODALITY TREATMENT WITH RADIOCHEMOTHERAPY AND ERLOTINIB IN ADVANCED NSCLC (MARTE TRIAL). 17
Addressing the crisis: the looming shortage of radiation oncologists and the urgency for action 17
Delayed surgery after radio-chemotherapy for rectal adenocarcinoma is protective for anastomotic dehiscence: a single centre retrospective analysis 16
¹⁸F-choline positron emission tomography/computed tomography-driven high-dose salvage radiation therapy in patients with biochemical progression after radical prostatectomy: feasibility study in 60 patients 16
Role of CA 19.9 in the Management of Resectable Pancreatic Cancer: State of the Art and Future Perspectives 15
Preventing Cardiotoxicity in Personalized Breast Irradiation 14
Radiotherapy for HER 2 Positive Brain Metastases: Urgent Need for a Paradigm Shift 14
Ablative Five-Fraction Stereotactic Radiotherapy in Elderly Patients with Pancreatic Cancer: A Single Institution Experience 14
Combination of novel systemic agents and radiotherapy for solid tumors - Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity. 14
OA24.02 - Locally Advanced Non-Small Cell Lung Cancer: RadioTherapy with Adaptive Strategy (LARTIA Trial) 14
Radiomics-based prediction of overall survival in lung cancer using different volumes-of-interest 14
Thoracic Radiotherapy in Extensive Disease Small Cell Lung Cancer: Multicenter Prospective Observational TRENDS Study 13
Pancreatic cancer care: Lighting the way with the torch of staging laparoscopy and advanced imaging 13
PATTERN OF FAILURE AFTER ADAPTIVE RADIOCHEMOTHERAPY FOR LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (LA-NSCLC). 13
Safety and efficacy of combined radiotherapy, immunotherapy and targeted agents in elderly patients: A literature review 12
Special Issue “Hepatobiliary and Pancreatic Cancers: Novel Strategies for of Diagnosis and Treatments” 12
In Regard to Parikh et al 12
Radiotherapy and vascular endothelial growth factor receptor-tyrosine kinase inhibitors in renal cancer 12
Erlotinib and concurrent chemoradiation in pretreated NSCLC patients: radiobiological basis and clinical results. 12
Role of induction therapy in esophageal cancer 12
Efficacy of a Propolis-Based Syrup (FARINGEL) in Preventing Radiation-Induced Esophagitis in Locally Advanced Lung Cancer. 12
Somatostatin analogs and disease control in castration-resistant prostate cancer: different biological behavior? Case series and review of the literature 12
Heterotopic hip ossification resection: monocentric experiences of associated factors, outcomes, and complications 11
In Reply to Riou et al 11
Induction chemotherapy with cisplatin, 5-fluorouracil, and cetuximab followed by radiotherapy and cetuximad in head and neck cancers: Preliminary results of a modern integrated approach 11
Whole-Breast Irradiation: A Subgroup Analysis of Criteria to Stratify for Prone Position Treatment 11
Precision radiotherapy by SPECT lung functional imaging in NSCLC 11
Multimodality treatment of stage III non-small cell lung cancer: analysis of a phase II trial using preoperative cisplatin and gemcitabine with concurrent radiotherapy 10
PV-0276 Adaptive radiotherapy: rate of "marginal" failure after "replanning" in combined treatment of NSCLC. 10
SBRT: A viable option for treating adrenal gland metastases 10
Combined modality therapy for thoracic and head and neck cancers: A review of updated literature based on a consensus meeting 9
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 9
Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2 9
Molecularly targeted therapy and radiotherapy in the management of localized gastrointestinal stromal tumor (GIST) of the rectum: a case report 9
Prognostic Score in Radiotherapy Practice for Palliative Treatments (PROPHET) Study for Bone Metastases: An Investigation Into the Clinical Effect on Treatment Prescription 8
Evaluation of Italian radiotherapy research from 1985 to 2005: preliminary analysis 8
Stereotactic body radiotherapy vs conventionally fractionated chemoradiation in locally advanced pancreatic cancer: A multicenter case-control study (PAULA-1) 8
Neoadjuvant chemoradiation in locally advanced NSCLC: impact of histology and drugs on results. 8
Stereotactic body radiation therapy for early stage NSCLC: clinical outcomes 8
The role of mammography after breast-conserving surgery and adjuvant chemotherapy 8
PAIDEIA: pacemaker and implanted cardioverter defibrillator management in radiation therapy—a survey by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 7
NeoAdjuvant chemoradiation for pancreatic cancer results of an ongoing trial 7
Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude study 6
Comparative Effectiveness of Chemotherapy Alone Versus Radiotherapy-Based Regimens in Locally Advanced Pancreatic Cancer: A Real-World Multicenter Analysis (PAULA-1) 6
Volume de-escalation in radiation therapy: state of the art and new perspectives 6
Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 1 6
Radiation treatment for adult rare cancers: Oldest and newest indication 5
Definition of local recurrence site in resected pancreatic adenocarcinoma: A multicenter study (dolores-1) 4
Totale 1.817
Categoria #
all - tutte 23.957
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.957


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022117 0 1 2 4 1 3 5 3 13 1 0 84
2022/202379 0 1 2 3 6 1 22 6 7 0 22 9
2023/2024306 11 26 19 15 27 118 14 20 3 17 12 24
2024/20251.315 46 24 146 68 60 116 71 32 279 425 48 0
Totale 1.817